Clinical trials
Observational Bile Duct Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 4 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Scientific Corporation | 2 |
| Methodist Health System | 2 |
| Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University | 1 |
| AdventHealth | 1 |
| Air Force Military Medical University, China | 1 |
| Changi General Hospital | 1 |
| Clinical Hospital Colentina | 1 |
| Fundacion Miguel Servet | 1 |
| IRCCS San Raffaele | 1 |
| Innovative Digestive Health Education and Research Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bile Duct Diseases | 18 |
| Pancreatic Diseases | 7 |
| Cholestasis | 4 |
| Digestive System Diseases | 4 |
| Bile Duct Neoplasms | 3 |
| Cholangitis | 3 |
| Pancreatic Neoplasms | 3 |
| Cholangiocarcinoma | 2 |
| Gallstones | 2 |
| Gastrointestinal Diseases | 2 |
Trials
Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.